Metabolomic characterization of nipple aspirate fluid by 1H NMR spectroscopy and GC-MS

Journal of Proteome Research

Volumn 13, Issue 2, 2014, Pages 883-889

  Tredwell, Gregory D ^a   Miller, Jessica A ^b   Chow, H H Sherry ^b   Thompson, Patricia A ^b   Keun, Hector C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

breast cancer; GC MS; metabolomics; metabonomics; nipple aspirate fluid; NMR

Indexed keywords

BODY FLUIDS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; NIPPLES; POSTMENOPAUSE; PREMENOPAUSE;

EID: 84893865555     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400924k     Document Type: Article

References (28)

1. Nowsheen, S. Molecular markers for cancer prognosis and treatment: Have we struck gold? Cancer Lett. 2012, 327 (1-2) 142-152
2. Higgins, S. A. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer Breast Cancer Res. 2005, 7 (6) R1017-R1022
3. Maskarinec, G. The volume of nipple aspirate fluid is not affected by 6 months of treatment with soy foods in premenopausal women J. Nutr. 2011, 141 (4) 626-630
4. Mannello, F. Intracrinology of breast microenvironment: hormonal status in nipple aspirate fluid and its relationship to breast cancer Expert Rev. Endocrinol. Metab. 2009, 4 (5) 493-505
5. Dooley, W. C. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer J. Natl. Cancer Inst. 2001, 93 (21) 1624-1632
6. Sauter, E. R. Nipple aspirate fluid and ductoscopy to detect breast cancer Diagn. Cytopathol. 2009, 38 (4) 244-251
7. Malatesta, M. Biochemical and ultrastructural features of human milk and nipple aspirate fluids J. Clin. Lab. Anal. 2000, 14 (6) 330-335
8. Petrakis, N. L. Physiologic, biochemical, and cytologic aspects of nipple aspirate fluid Breast Cancer Res. Treat. 1986, 8 (1) 7-19
9. Sauter, E. R. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk Br. J. Cancer 1997, 76 (4) 494-501
10. Petrakis, N. L. Gross cystic disease fluid protein in nipple aspirates of breast fluid of Asian and non-Asian women Cancer Epidemiol. Biomarkers Prev. 1993, 2 (6) 573-579
11. Thompson, P. A. Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I trial Cancer Prev. Res. 2010, 3 (1) 101-107
12. Miller, J. A. Expression of epidermal growth factor, transforming growth factor-beta 1 and adiponectin in nipple aspirate fluid and plasma of pre and post-menopausal women Biomarker Res. 2013, 1, 18
13. Varnum, S. M. Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer Breast Cancer Res. Treat. 2003, 80 (1) 87-97
14. Mannello, F. Protein profile analysis of the breast microenvironment to differentiate healthy women from breast cancer patients Expert Rev. Proteomics 2009, 6 (1) 43-60
15. Pawlik, T. M. Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry Breast Cancer Res. Treat. 2005, 89 (2) 149-157
16. Pawlik, T. M. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein BMC Cancer 2006, 6, 68
17. Sauter, E. R. Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS Int. J. Cancer 2004, 114 (5) 791-796
18. Keun, H. Serum molecular signatures of weight change during early breast cancer chemotherapy Clin. Cancer Res. 2009, 15 (21) 6716
19. Stebbing, J. A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy Ann. Oncol. 2012, 23 (4) 860-866
20. Denkert, C. Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery Genome Med. 2012, 4 (4) 37
21. Miller, T. P. Safety and feasibility of topical application of limonene as a massage oil to the breast J. Cancer Ther. 2012, 3, 749-54
22. Beckonert, O. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2007, 2 (11), 2692-2703.
23. Sauter, E. R. Nipple aspirate fluid color is associated with breast cancer Cancer Detect. Prev. 2006, 30 (4) 322-328
24. Petrakis, N. L. Coloration of breast fluid related to concentration of cholesterol, cholesterol epoxides, estrogen, and lipid peroxides Am. J. Clin. Pathol. 1988, 89 (1) 117-120
25. Kind, T. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry Anal. Chem. 2009, 81 (24) 10038-10048
26. Stein, S. E. An integrated method for spectrum extraction and compound identification from GC/MS Data J. Am. Soc. Mass Spectrom. 1999, 10, 770-781
27. Behrends, V. A software complement to AMDIS for processing GC-MS metabolomic data Anal. Biochem. 2011, 415 (2) 206-208
28. 1H NMR metabonomics Anal. Chem. 2006, 78 (13) 4281-4290